Synchron logo

Synchron

Paid

Implantable Brain-Computer Interfaces to protect what makes you human.

4.5
Type
Saas
Company
Synchron

About Synchron

Synchron is a medical technology company pioneering interventional brain-computer interfaces (BCIs) that can be implanted via a minimally invasive stent-like procedure through the jugular vein, avoiding the need for open brain surgery. Their first product, Stentrode™, is an investigational device currently in clinical trials in the USA and Australia, designed to restore communication, independence, and agency for people living with paralysis. Synchron's vision is to restore, extend, and protect human agency, with a first mission to release motor models that improve agency for 15 million people with motor impairment, and a second mission to address cognitive decline for 500 million people.

Key Features

Minimally invasive stent-like implantation via the jugular vein, no open brain surgery required
Stentrode device designed to restore communication, independence, and agency for people with paralysis
Currently in clinical trials in the USA and Australia for motor impairment
Pioneering interventional BCI category to scale neural interfaces for millions
Focus on protecting human agency through ethical principles: agency, freedom, flourishing

Pros & Cons

Pros
  • No open brain surgery required, reducing risks and recovery time
  • Minimally invasive procedure similar to stent placement in cardiology
  • Potential to scale BCI technology to serve millions of people
  • Ethical focus on preserving human agency and mental privacy
Cons
  • Investigational device limited by law to clinical trials, not yet commercially available
  • Clinical trials ongoing, long-term efficacy and safety data still being gathered
  • Only targeted at severe motor impairment at this stage, not general population

Best For

Restoring communication for people with paralysisRestoring independence and agency for individuals with motor impairmentAddressing cognitive decline for people with neurological conditions (future mission)

Alternatives to Synchron

FAQ

What is Synchron's approach to brain-computer interfaces?
Synchron uses a minimally invasive stent-like procedure to implant their Stentrode device via the jugular vein, avoiding open brain surgery. The device is designed to restore communication, independence, and agency for people with paralysis.
Is Synchron's Stentrode available to the public?
No. Stentrode is an investigational device limited by federal law to investigational use only, and is currently being assessed in clinical trials in the USA and Australia.
What ethical principles guide Synchron?
Synchron follows ethical principles of agency (self-determination), freedom (cognitive sovereignty and mental privacy), and flourishing (a life worth living), aiming to protect human agency as intelligence accelerates.